Audited Report & Accounts published on website
RNS: RELEASE 30 April 2020
ImmuPharma PLC
("ImmuPharma" or the "Company")
Audited Report & Accounts published on website
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Audited Annual Report and Accounts ("Report") for the year ended 31 December 2019, has today been published on the Company's website. Copies of this Report, including the Notice of Annual General Meeting, will be posted to shareholders in the near future.
Confirmation of this date will be announced to the market on the day of posting. To view the Report please go to: www.immupharma.co.uk.
For further information please contact:
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.